Logo


Cadila Healthcare consolidated Q4 net up 53% to Rs 59 bn; income grows 27%

Standalone profit down 48% to Rs 24.3 bn; company gets board nod for fund raising proposals

Drug firms, Lupin, Cadila Healthcare
Drug firms, Lupin, Cadila Healthcare

Ahmedabad-based Cadila Healthcare (Zydus Cadila) registered a 53.55 per cent rise in its consolidated net profit for the fourth quarter ended March 31, 2018 for the fiscal 2017-18 to close at Rs 59.08 billion. As per the company's filing on the BSE, its consolidated net profit for the corresponding period last year was Rs 38.55 billion. Cadila Healthcare's consolidated total income grew by 26.77 per cent to stand at Rs 327.89 billion in Q4 of FY18, up from Rs 258.64 billion in Q4 of FY17. On a standalone basis, Zydus Cadila's Q4 net profit fell by 48.40 per cent to close at ...